McCann Wins $20 Mil. Zicam Brands

LOS ANGELES Interpublic Group’s McCann Erickson has been assigned creative and media duties for Matrixx Initiatives’ Zicam brands over-the-counter drugs for cold and allergy symptoms, the agency confirmed.

There was no competitive review. Estimated billings are $20 million.

Ian McGregor, executive vice president and general manager of McCann in Los Angeles, said the Phoenix-based pharmaceuticals company especially valued the agency’s strategic thinking and its “holistic approach to ‘demand creation’ using the full range of [McCann] Worldgroup services.”

“We built the brand from nothing to 30 percent annual compound sales every year for 5 years in a row,” said Lee Kovel, chief creative officer at incumbent Kovel/Fuller, an independent agency in Culver City, Calif. “And [Zicam] went from one product to launching over 12. We wish them the best.”

McCann’s clients include Nestle, International House of Pancakes, Northrup Grumman, Sony and Pepperdine University.

Matrixx spent $17 million on advertising in 2003 and $9 million through August 2004, according to Nielsen Monitor-Plus.

This article has been updated with the incumbent’s comment.